In This Article:
AMSTERDAM (AP) — AMSTERDAM (AP) — UniQure NV (QURE) on Friday reported a loss of $43.6 million in its first quarter.
On a per-share basis, the Amsterdam-based company said it had a loss of 82 cents.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.07 per share.
The human gene therapy company posted revenue of $1.6 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on QURE at https://www.zacks.com/ap/QURE